4D pharma : Announces Two Presentations at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022)

(marketscreener.com) Leeds, UK - October 5, 2022 - 4D pharma plc , a pharmaceutical company leading the development of Live Biotherapeutic products , a novel class of drug derived from the microbiome, today announces two poster presentations at the Society for Immunotherapy of Cancer's 37th Annual Meeting , held from November 8-12, 2022. The two...https://www.marketscreener.com/quote/stock/4D-PHARMA-PLC-56171591/news/4D-pharma-Announces-Two-Presentations-at-The-Society-for-Immunotherapy-of-Cancer-Annual-Meeting-S-41933090/?utm_medium=RSS&utm_content=20221005